Parkinson's Disease Dementia Can Be Easily Detected in Routine Clinical Practice

被引:36
|
作者
Dujardin, Kathy [1 ]
Dubois, Bruno [2 ]
Tison, Francois [3 ]
Durif, Franck [4 ]
Bourdeix, Isabelle [5 ]
Pere, Jean-Jacques [5 ]
Duhamel, Alain [6 ]
机构
[1] Univ Lille, Med Ctr, Univ Lille Nord France, UDSL,CNRS FRE3291,Neurol & Movement Disorders Uni, Lille, France
[2] Univ Paris 06, Salpetriere Hosp, AP HP, INSERM UPMC UMRS 610, Paris, France
[3] Univ Bordeaux, Dept Neurol, Bordeaux Univ Med Ctr, Bordeaux, France
[4] Univ Clermont Ferrand, Med Ctr, Gabriel Montpied Hosp, Dept Neurol, Clermont Ferrand, France
[5] Novartis Pharma SAS, Rueil Malmaison, France
[6] Univ Lille, Med Ctr, Univ Lille Nord France, UDSL,EA2694,Biostat Dept, Lille, France
关键词
Parkinson's disease; dementia; cognition; screening procedures; basal ganglia; MONTREAL COGNITIVE ASSESSMENT; ALZHEIMERS-DISEASE; DIAGNOSTIC-CRITERIA; BEDSIDE ASSESSMENT; PREVALENCE; RIVASTIGMINE; IMPAIRMENT; VALIDITY; DECLINE; PROFILE;
D O I
10.1002/mds.23391
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Parkinson's disease (PD) is mainly characterized by its motor manifestations, but it is also frequently associated with dementia. Early diagnosis of PD dementia (PDD) is particularly important because effective cholinesterase inhibitor treatments are available. This study aimed at validating a short procedure for screening for PDD in routine clinical practice and which adopts recently published diagnostic criteria. One hundred eighty-eight patients with PD participated in the study. The examination procedure comprised three steps: standard clinical examination, a short cognitive function assessment fulfilling the requirements of the Movement Disorders Society (Mini Mental State Examination, five-word test, word generation task, and impact on daily life, including a questionnaire on compliance with medication) and an extensive evaluation of cognitive functions and behavior. After each step, the suspected presence or absence of dementia was recorded. After the short cognitive function assessment, PDD was suspected in 18.62% of the patients [95% confidence interval (CI): 13.32-24.93%]. After the extensive assessment, 21.81% (95% CI: 16.13-28.40%) met the criteria for probable PDD. The short battery's sensitivity and specificity were 65.85% (95% CI = 49.41-79.92%) and 94.56% (95% CI = 89.56-97.62%), respectively. A stepwise logistic regression analysis showed that use of a specific cutoff considerably enhanced the short battery's sensitivity (85.37%, 95% CI = 70.83-94.43%) without decreasing its specificity (83.67%, 95% CI = 76.69-89.25%). With an easy-to-use, short battery of tests that are commonly used in routine clinical practice, it is possible to diagnose PDD in accordance with reference criteria and with the same sensitivity and specificity as in a more extensive evaluation. (C) 2010 Movement Disorder Society
引用
收藏
页码:2769 / 2776
页数:8
相关论文
共 50 条
  • [1] Detection of Parkinson's disease dementia in routine practice
    Dujardin, K.
    Duhamel, A.
    Tison, F.
    Pere, J. J.
    Bourdeix, I.
    Dubois, B.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S36 - S36
  • [2] DIFFICULTIES IN DIAGNOSING PARKINSON'S DISEASE WITH DEMENTIA AND DEMENTIA WITH LEWY BODIES IN CLINICAL PRACTICE
    Khabarova, Yu, I
    Tappakhov, A. A.
    Popova, T. E.
    YAKUT MEDICAL JOURNAL, 2022, (04): : 120 - 123
  • [3] Pramipexole in routine clinical practice -: A prospective observational trial in Parkinson's disease
    Reichmann, H
    Brecht, MH
    Köster, F
    Kraus, PH
    Lemke, MR
    CNS DRUGS, 2003, 17 (13) : 965 - 973
  • [4] Safety of safinamide in routine clinical practice in a Spanish population with Parkinson's disease
    Esquivel, A.
    Freire, E.
    Gomez-Esteban, J.
    Kulisevsky-Bojarski, J.
    Legarda-Ramirez, I.
    Alvarez-Santullo, M. Mata
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 513 - 513
  • [5] Diagnosis of dementia in Parkinson's disease: a retrospective and a validation study in the clinical practice
    Vanacore, N.
    Stirpe, P.
    Giustini, P.
    Di Battista, E.
    Bernardi, S.
    Meco, G.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S38 - S38
  • [6] Can neuroimaging predict dementia in Parkinson's disease?
    Lanskey, Juliette H.
    McColgan, Peter
    Schrag, Anette E.
    Acosta-Cabronero, Julio
    Rees, Geraint
    Morris, Huw R.
    Weil, Rimona S.
    BRAIN, 2018, 141 : 2545 - 2560
  • [7] Comparison of Movement Disorder Society Criteria for Parkinson's Disease Dementia with Routine Clinical Neuropsychological Testing
    Barton, Brandon
    Bernard, Bryan
    Stebbins, Glenn
    Goldman, Jennifer
    Dubois, Bruno
    Goetz, Christopher
    NEUROLOGY, 2012, 78
  • [8] Comparison of The Movement Disorder Society criteria for Parkinson's disease dementia with routine clinical neuropsychological testing
    Barton, B. R.
    Bernard, B.
    Stebbins, G. T.
    Goldman, J.
    Dubois, B.
    Goetz, C. G.
    MOVEMENT DISORDERS, 2012, 27 : S11 - S12
  • [9] Rotigotine transdermal patch in combination therapy for Parkinson's disease - observations in routine clinical practice
    Ceballos-Baumann, Andres
    Haeck, Hermann-Josef
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (10) : 1899 - 1905
  • [10] Clinical Trials of Dementia With Lewy Bodies and Parkinson’s Disease Dementia
    D. Aarsland
    C. Ballard
    A. Rongve
    M. Broadstock
    P. Svenningsson
    Current Neurology and Neuroscience Reports, 2012, 12 : 492 - 501